Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Endothelial Function in OSAS
NCT03545997Phase 3Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of montelukast in obstructive sleep apnea (OSA), sponsored by CHU Grenoble Alpes. Started Nov 2019; status: terminated.
02
Drugs
montelukast
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03545997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03545997.